{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:19:37Z","timestamp":1763399977432,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ymgmr.2021.100725","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T21:50:15Z","timestamp":1612907415000},"page":"100725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland"],"prefix":"10.1016","volume":"27","author":[{"given":"Markku J.","family":"Savolainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samppa","family":"Rohkimainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iiro","family":"Toppila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariann I.","family":"Lassenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Vaca","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Uusi-Rauva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Elomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2021.100725_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"IJMS"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0005-2760(82)90272-7","article-title":"The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of gaucher\u2019s disease","volume":"712","author":"Nilsson","year":"1982","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0035","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0045","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.expneurol.2017.09.010","article-title":"Insights into the structural biology of Gaucher disease","volume":"298","author":"Smith","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2017.08.002","article-title":"Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians","volume":"122","author":"Mehta","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0065","first-page":"7","article-title":"Gaucher disease: new expanded classification emphasizing neurological features","volume":"13","author":"Alaei","year":"2019","journal-title":"Iran J Child Neurol."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15227950500405296","article-title":"Perinatal lethal GAUCHER disease: a distinct phenotype along the NEURONOPATHIC continuum","volume":"24","author":"Eblan","year":"2005","journal-title":"Fetal and Pediatric Pathology."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0080","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/ajh.24063","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher registry: phenotypes of Gaucher disease types 1 and 3","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/cancers12020475","article-title":"Are glucosylceramide-related sphingolipids involved in the increased risk for Cancer in Gaucher disease patients? Review and hypotheses","volume":"12","author":"Dubot","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0090","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0100","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher\u2019s disease","volume":"17","author":"Mehta","year":"2006","journal-title":"European Journal of Internal Medicine."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher\u2019s disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/imj.14156","article-title":"Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative","volume":"49","author":"Mehta","year":"2019","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0120","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/imj.14942","article-title":"Scoring system to facilitate diagnosis of Gaucher disease","volume":"50","author":"Mehta","year":"2020","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1212\/WNL.46.4.1102","article-title":"Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease","volume":"46","author":"Seeman","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2021.100725_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/10425179809020896","article-title":"Simple PCR amplification of the entire Glucocerebrosidase gene (GBA) coding region for diagnostic sequence analysis","volume":"8","author":"Finckh","year":"1998","journal-title":"DNA Seq."},{"key":"10.1016\/j.ymgmr.2021.100725_bb0135","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.3390\/ijms21197159","article-title":"Value of Glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review","volume":"21","author":"Revel-Vilk","year":"2020","journal-title":"IJMS"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:38Z","timestamp":1762001498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":27,"alternative-id":["S2214426921000197"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100725","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100725"}}